Media-OutReach Newswire Abivax receives ANSM and Ethics Committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized Phase 2b/3 clinical trial
ICONSIAM Showcases Thai Creativity to the World with "Lost in DOMLAND" — Reinforcing Its Role as a Must-Visit Global Art Destination 1.